|
OTUD6B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.602600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.841900E-02 |
| Normal-vs-Stage2 |
3.193800E-01 |
| Normal-vs-Stage3 |
2.290300E-02 |
| Normal-vs-Stage4 |
3.355500E-03 |
| Stage1-vs-Stage2 |
8.453400E-01 |
| Stage1-vs-Stage3 |
4.751200E-01 |
| Stage1-vs-Stage4 |
1.520550E-01 |
| Stage2-vs-Stage3 |
5.394600E-01 |
| Stage2-vs-Stage4 |
3.408200E-01 |
| Stage3-vs-Stage4 |
6.205600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.040400E-03 |
| Normal-vs-AfricanAmerican |
2.303800E-02 |
| Normal-vs-Asian |
8.488400E-01 |
| Caucasian-vs-AfricanAmerican |
8.000000E-01 |
| Caucasian-vs-Asian |
3.515400E-01 |
| AfricanAmerican-vs-Asian |
2.282800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.703000E-03 |
| Normal-vs-Female |
1.181750E-01 |
| Male-vs-Female |
1.179950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.915900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.825800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.039870E-02 |
| Normal-vs-Age(81-100Yrs) |
5.028500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.866400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.150400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.946800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.831600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.101000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.260600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.136000E-01 |
| Normal-vs-Grade 2 |
2.535600E-01 |
| Normal-vs-Grade 3 |
2.24689999999139E-05 |
| Normal-vs-Grade 4 |
1.761720E-03 |
| Grade 1-vs-Grade 2 |
2.388000E-01 |
| Grade 1-vs-Grade 3 |
5.859700E-03 |
| Grade 1-vs-Grade 4 |
3.892300E-02 |
| Grade 2-vs-Grade 3 |
3.235100E-03 |
| Grade 2-vs-Grade 4 |
2.202100E-02 |
| Grade 3-vs-Grade 4 |
7.512800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.637830E-01 |
| Normal-vs-ccB subtype |
5.186500E-02 |
| ccA subtype-vs-ccB subtype |
4.385000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.158000E-02 |
| Normal-vs-N1 |
1.293600E-01 |
| N0-vs-N1 |
6.876200E-01 |
|
|
